Change search
ReferencesLink to record
Permanent link

Direct link
Management of neuronopathic Gaucher disease: revised recommendations
Show others and affiliations
2009 (English)In: Journal of Inherited Metabolic Disease, ISSN 0141-8955, E-ISSN 1573-2665, Vol. 32, no 5, 660-664 p.Article in journal (Refereed) Published
Abstract [en]

The original guidelines drawn up for the management of the neuronopathic forms of Gaucher disease were felt to be in need of revision; in particular, the role of high-dose enzyme replacement therapy (120 IU/kg of body weight every 2 weeks) in stabilizing neurological disease. The existing published evidence was analysed; it was concluded that it did not support the role of high-dose ERT, although this might be required to treat severe visceral disease.

Place, publisher, year, edition, pages
Springer, 2009. Vol. 32, no 5, 660-664 p.
Keyword [en]
neuronopathic, Gaucher disease, revised recommendations
National Category
URN: urn:nbn:se:umu:diva-35056DOI: 10.1007/s10545-009-1164-2PubMedID: 19655269OAI: diva2:328508
Available from: 2010-07-05 Created: 2010-07-05 Last updated: 2012-11-13Bibliographically approved

Open Access in DiVA

No full text

Other links

Publisher's full textPubMed

Search in DiVA

By author/editor
Erikson, Anders
By organisation
In the same journal
Journal of Inherited Metabolic Disease

Search outside of DiVA

GoogleGoogle Scholar
The number of downloads is the sum of all downloads of full texts. It may include eg previous versions that are now no longer available

Altmetric score

Total: 24 hits
ReferencesLink to record
Permanent link

Direct link